Article Details

Arcutis stock soars on drug trial news; company announces $150M capital raise

Retrieved on: 2021-02-02 01:52:30

Tags for this article:

Click the tags to see associated articles and topics

Arcutis stock soars on drug trial news; company announces $150M capital raise. View article details on hiswai:

Excerpt

Morgan Stanley, Cowen, and Guggenheim Securities are acting as bookrunning managers, and Truist Securities and Cantor are acting as lead ...

Article found on: www.pacbiztimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up